Penumbra Debt to Equity Ratio 2014-2019 | PEN
Current and historical debt to equity ratio values for Penumbra (PEN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Penumbra debt/equity for the three months ending September 30, 2019 was 0.10.
| Penumbra Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-09-30 | $0.05B | $0.47B | 0.10 |
| 2019-06-30 | $0.05B | $0.45B | 0.10 |
| 2019-03-31 | $0.05B | $0.44B | 0.11 |
| 2018-12-31 | $0.00B | $0.42B | 0.00 |
| 2018-09-30 | $0.00B | $0.41B | 0.00 |
| 2018-06-30 | $0.00B | $0.43B | 0.00 |
| 2018-03-31 | $0.00B | $0.42B | 0.00 |
| 2017-12-31 | $0.00B | $0.40B | 0.00 |
| 2017-09-30 | $0.00B | $0.38B | 0.00 |
| 2017-06-30 | $0.00B | $0.37B | 0.00 |
| 2017-03-31 | $0.00B | $0.37B | 0.00 |
| 2016-12-31 | $0.00B | $0.27B | 0.00 |
| 2016-09-30 | $0.00B | $0.25B | 0.00 |
| 2016-06-30 | $0.00B | $0.25B | 0.00 |
| 2016-03-31 | $0.00B | $0.24B | 0.00 |
| 2015-12-31 | $0.00B | $0.23B | 0.00 |
| 2015-09-30 | $0.00B | $0.23B | 0.00 |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | 0.00 | |
| 2013-12-31 | $0.01B | $-0.01B | -0.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.601B | $0.445B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $135.030B | 27.97 |
| Intuitive Surgical (ISRG) | United States | $69.146B | 54.34 |
| Edwards Lifesciences (EW) | United States | $49.761B | 45.19 |
| IDEXX Laboratories (IDXX) | United States | $24.870B | 60.15 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $22.755B | 15.40 |
| Olympus (OCPNY) | Japan | $22.193B | 166.67 |
| DexCom (DXCM) | United States | $21.455B | 192.14 |
| Teleflex (TFX) | United States | $17.795B | 36.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.106B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.568B | 39.21 |
| Hologic (HOLX) | United States | $14.539B | 22.22 |
| Varian Medical Systems (VAR) | United States | $13.523B | 32.06 |
| STERIS (STE) | Ireland | $13.068B | 28.86 |
| Masimo (MASI) | United States | $9.058B | 54.09 |
| ABIOMED (ABMD) | United States | $8.193B | 44.58 |
| SARTORIUS AG (SARTF) | Germany | $6.731B | 59.08 |
| Globus Medical (GMED) | United States | $5.298B | 32.69 |
| Integra LifeSciences Holdings (IART) | United States | $5.178B | 22.25 |
| Elekta AB (EKTAY) | Sweden | $4.565B | 38.55 |
| Tandem Diabetes Care (TNDM) | United States | $4.108B | 0.00 |
| Nevro (NVRO) | United States | $3.839B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $3.834B | 232.38 |
| LivaNova (LIVN) | United Kingdom | $3.638B | 26.19 |
| Integer Holdings (ITGR) | United States | $2.903B | 19.87 |
| Cantel Medical (CMD) | United States | $2.626B | 25.70 |
| Nihon Kohden (NHNKY) | Japan | $2.447B | 24.63 |
| Glaukos (GKOS) | United States | $2.140B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.608B | 31.66 |
| Veracyte (VCYT) | United States | $1.474B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.295B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.208B | 138.04 |
| Natus Medical (NTUS) | United States | $1.159B | 27.87 |
| Mesa Laboratories (MLAB) | United States | $1.145B | 42.45 |
| Inogen (INGN) | United States | $1.139B | 35.97 |
| CryoLife (CRY) | United States | $1.114B | 114.23 |
| Luminex (LMNX) | United States | $1.069B | 0.00 |
| OPKO Health (OPK) | United States | $1.058B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.984B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.907B | 30.11 |
| OrthoPediatrics (KIDS) | United States | $0.798B | 0.00 |
| Intersect ENT (XENT) | United States | $0.786B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.771B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.698B | 0.00 |
| AxoGen (AXGN) | United States | $0.593B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.579B | 26.55 |
| Si-Bone (SIBN) | United States | $0.546B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.458B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.429B | 12.97 |
| Sientra (SIEN) | United States | $0.400B | 0.00 |
| Stereotaxis (STXS) | United States | $0.347B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.329B | 89.20 |
| Semler Scientific (SMLR) | United States | $0.327B | 45.46 |
| Accuray (ARAY) | United States | $0.305B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.304B | 0.00 |
| IRadimed (IRMD) | United States | $0.300B | 42.15 |
| ViewRay (VRAY) | United States | $0.290B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.290B | 80.80 |
| GenMark Diagnostics (GNMK) | United States | $0.288B | 0.00 |
| Fluidigm (FLDM) | United States | $0.273B | 0.00 |
| Restoration Robotics (VERO) | Canada | $0.178B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.129B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.122B | 32.31 |
| ConforMIS (CFMS) | United States | $0.089B | 0.00 |
| Electromed (ELMD) | United States | $0.081B | 29.15 |
| Neuronetics (STIM) | United States | $0.081B | 0.00 |
| Vermillion (VRML) | United States | $0.080B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.067B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.060B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.057B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.053B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.039B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.038B | 0.00 |
| TransEnterix (TRXC) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.029B | 0.00 |
| Neovasc (NVCN) | Canada | $0.028B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.027B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.026B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.021B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.017B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.015B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.015B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.015B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.014B | 20.35 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.011B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.010B | 0.00 |
| Dynatronics (DYNT) | United States | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
| InspireMD (NSPR) | Israel | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.001B | 0.00 |
